JOP20200101B1 - تخليق مشتقات إستر بورونات واستخداماتها - Google Patents

تخليق مشتقات إستر بورونات واستخداماتها

Info

Publication number
JOP20200101B1
JOP20200101B1 JOJO/P/2020/0101A JOP20200101A JOP20200101B1 JO P20200101 B1 JOP20200101 B1 JO P20200101B1 JO P20200101 A JOP20200101 A JO P20200101A JO P20200101 B1 JOP20200101 B1 JO P20200101B1
Authority
JO
Jordan
Prior art keywords
synthesis
ester derivatives
boronate ester
disclosure
formula
Prior art date
Application number
JOJO/P/2020/0101A
Other languages
Arabic (ar)
English (en)
Inventor
Serge Henri Boyer
Gerardus K M Verzijl
Petrus J Hermsen
Scott J Hecker
Original Assignee
Melinta Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melinta Therapeutics Inc filed Critical Melinta Therapeutics Inc
Publication of JOP20200101A1 publication Critical patent/JOP20200101A1/ar
Application granted granted Critical
Publication of JOP20200101B1 publication Critical patent/JOP20200101B1/ar

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/46Ruthenium, rhodium, osmium or iridium
    • B01J23/462Ruthenium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/31Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/04Esters of boric acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/002Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by oxidation/reduction reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JOJO/P/2020/0101A 2017-11-01 2020-05-06 تخليق مشتقات إستر بورونات واستخداماتها JOP20200101B1 (ar)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762580343P 2017-11-01 2017-11-01
PCT/US2018/058143 WO2019089542A1 (en) 2017-11-01 2018-10-30 Synthesis of boronate ester derivatives and uses thereof

Publications (2)

Publication Number Publication Date
JOP20200101A1 JOP20200101A1 (ar) 2022-10-30
JOP20200101B1 true JOP20200101B1 (ar) 2024-12-22

Family

ID=66245250

Family Applications (2)

Application Number Title Priority Date Filing Date
JOJO/P/2020/0101A JOP20200101B1 (ar) 2017-11-01 2020-05-06 تخليق مشتقات إستر بورونات واستخداماتها
JOJO/P/2024/0234A JOP20240234A1 (ar) 2017-11-01 2024-10-20 تخليق مشتقات إستر بورونات واستخداماتها

Family Applications After (1)

Application Number Title Priority Date Filing Date
JOJO/P/2024/0234A JOP20240234A1 (ar) 2017-11-01 2024-10-20 تخليق مشتقات إستر بورونات واستخداماتها

Country Status (14)

Country Link
US (3) US11999757B2 (https=)
EP (1) EP3704130A4 (https=)
JP (1) JP7480050B2 (https=)
KR (1) KR20200076730A (https=)
CN (2) CN111556872B (https=)
AU (1) AU2018360502B2 (https=)
CA (1) CA3080763A1 (https=)
CL (1) CL2020001143A1 (https=)
CO (1) CO2020006299A2 (https=)
JO (2) JOP20200101B1 (https=)
MX (2) MX2020004425A (https=)
PH (1) PH12020550544A1 (https=)
SG (1) SG11202003762VA (https=)
WO (1) WO2019089542A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111556872B (zh) 2017-11-01 2024-05-10 梅琳塔治疗公司 硼酸酯衍生物的合成及其用途
CN116789689B (zh) * 2023-06-21 2026-03-20 清华大学 硼代萘系化合物及其制备方法和应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783443A (en) 1986-03-03 1988-11-08 The University Of Chicago Amino acyl cephalosporin derivatives
JP2852545B2 (ja) 1989-11-14 1999-02-03 チッソ株式会社 複数の不斉点を持つ光学活性化合物および製造法
CA2165996C (en) 1995-12-22 2002-01-29 Murray Douglas Bailey Stereoselective preparation of 2-substituted succinic derivatives
FR2745288B1 (fr) 1996-02-27 1998-04-17 Adir Nouveaux derives de l'acide boronique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE19917979A1 (de) 1999-04-21 2000-10-26 Clariant Gmbh Verfahren zur Herstellung von substituierten Phenyl-boronsäuren
AU5104300A (en) 1999-06-04 2000-12-28 Kaneka Corporation Processes for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives
DE10032017A1 (de) 2000-07-01 2002-01-10 Clariant Gmbh Verfahren zur Herstellung hochreiner Formylphenylboronsäuren
DE10112401A1 (de) * 2001-03-13 2002-09-19 Degussa Alkohol-Dehydrogenase und deren Verwendung
DE10119274A1 (de) * 2001-04-20 2002-10-31 Juelich Enzyme Products Gmbh Enzymatisches Verfahren zur enantioselektiven Reduktion von Ketoverbindungen
JP4824874B2 (ja) * 2001-07-19 2011-11-30 高砂香料工業株式会社 光学活性γ−ブチロラクトンの製造方法
ES2544579T3 (es) * 2002-07-30 2015-09-01 Takasago International Corporation Procedimiento de producción de un beta-aminoácido ópticamente activo
TWI372725B (en) 2004-01-30 2012-09-21 Semequip Inc Methods of synthesis of isotopically enriched borohydride and methods of synthesis of isotopically enriched boranes
DE102004022397A1 (de) * 2004-05-06 2005-12-01 Consortium für elektrochemische Industrie GmbH Chirale C2-symmetrische Biphenyle, deren Herstellung sowie Metallkomplexe enthaltend diese Liganden und deren Verwendung als Katalysatoren in chirogenen Synthesen
WO2007034909A1 (ja) * 2005-09-22 2007-03-29 Kaneka Corporation (3r,5r)-7-アミノ-3,5-ジヒドロキシヘプタン酸誘導体の製造法
GB2474687A (en) 2009-10-23 2011-04-27 Phoenix Chemicals Ltd A continuous process for the production of (R)-6-cyano-5-hydroxy-3-oxo-hexanoic acid tert-butyl ester (and derivatives)
CA2807546C (en) 2010-08-10 2022-08-23 Rempex Pharmaceuticals, Inc. Cyclic boronic acid ester derivatives and therapeutic uses thereof
WO2013056163A1 (en) 2011-10-14 2013-04-18 The Regents Of The University Of California Beta-lactamase inhibitors
EP2814483A2 (en) * 2012-02-15 2014-12-24 Rempex Pharmaceuticals, Inc. Methods of treating bacterial infections
CN104395326B (zh) 2012-08-20 2017-04-05 玛耐科股份有限公司 二取代硼酸衍生物的制造方法和新型二取代硼酸衍生物
CN102965403A (zh) 2012-11-19 2013-03-13 苏州汉酶生物技术有限公司 (3r,5s)-6-氯-3,5-二羟基己酸叔丁酯的生物制备方法
AU2013355110B2 (en) * 2012-12-07 2017-11-09 VenatoRx Pharmaceuticals, Inc. Beta-lactamase inhibitors
PT3369724T (pt) 2013-11-05 2021-02-10 Bracco Imaging Spa Processo para a preparação de iopamidol
ES2750805T3 (es) * 2014-05-05 2020-03-27 Rempex Pharmaceuticals Inc Síntesis de sales de boronato y usos de las mismas
CN111556872B (zh) 2017-11-01 2024-05-10 梅琳塔治疗公司 硼酸酯衍生物的合成及其用途

Also Published As

Publication number Publication date
SG11202003762VA (en) 2020-05-28
US20190127396A1 (en) 2019-05-02
CA3080763A1 (en) 2019-05-09
US11999757B2 (en) 2024-06-04
EP3704130A1 (en) 2020-09-09
WO2019089542A1 (en) 2019-05-09
MX2020004425A (es) 2020-08-06
AU2018360502B2 (en) 2024-05-02
MX2023000529A (es) 2023-02-13
JP2021501205A (ja) 2021-01-14
KR20200076730A (ko) 2020-06-29
CN118388347A (zh) 2024-07-26
US20200308197A1 (en) 2020-10-01
JOP20200101A1 (ar) 2022-10-30
JP7480050B2 (ja) 2024-05-09
JOP20240234A1 (ar) 2024-10-20
US20240279248A1 (en) 2024-08-22
CN111556872B (zh) 2024-05-10
EP3704130A4 (en) 2021-07-07
CN111556872A (zh) 2020-08-18
CL2020001143A1 (es) 2020-10-30
CO2020006299A2 (es) 2020-06-09
AU2018360502A1 (en) 2020-06-04
BR112020008498A2 (pt) 2020-10-20
PH12020550544A1 (en) 2021-03-22

Similar Documents

Publication Publication Date Title
PH12019502286A1 (en) Process for preparing an optically active pyrimidinium compounds
BR112017020993A2 (pt) compostos, processo para a síntese de compostos, composição, uso de um composto da fórmula i, método para combater fungos fitopatogênicos, e, semente.
MX2015014688A (es) Tiazoles y usos de los mismos.
JOP20240234A1 (ar) تخليق مشتقات إستر بورونات واستخداماتها
MY199318A (en) Process for preparing chiral 2,3-dihydrothiazolo[3,2-a]pyrimidin-4-ium compounds
MX2016011898A (es) Composiciones de compuestos selenoorganicos y metodos de uso de los mismos.
MX2017016152A (es) Modelado de fibras de queratina mediante el uso de compuestos de dialdehido.
NZ736970A (en) Process methods for phosphatidylinositol 3-kinase inhibitors
MX2017003238A (es) Metodo para preparar 2'-o-fucosil-lactosa.
WO2017064627A3 (en) Process for preparation of eribulin and intermediates thereof
MX348979B (es) Agente de control de enfermedades de las plantas.
MX2016016730A (es) Metodo para preparar un producto intermedio de eribulina.
SA517390095B1 (ar) محفز تلمرة بيوتادايين وتحضيره
EP4282973A3 (en) Processes for the preparation of pyrimidinylcyclopentane compounds
EA201891866A1 (ru) N,N-ДИМЕТИЛ-3-[[5-(3-МЕТИЛ-2-ОКСО-1-ТЕТРАГИДРОПИРАН-4-ИЛ-ИМИДАЗО[4,5-c]ХИНОЛИН-8-ИЛ)-2-ПИРИДИЛ]ОКСИ]ПРОПАН-1-АМИНОКСИД В КАЧЕСТВЕ МОДУЛЯТОРА АТМ-КИНАЗЫ (МУТАЦИИ АТАКСИИ-ТЕЛЕАНГИЭКТАЗИИ) ДЛЯ ЛЕЧЕНИЯ РАКА
WO2016014864A8 (en) Hydroxy-(r),(r)-2,2'-bismethylnaltrexones and uses thereof
PL410423A1 (pl) 4-chloro-2-metylofenoksyoctany alkoksymetylobis(2-hydroksyetylo)metyloamoniowe,  sposób otrzymywania i zastosowanie jako środków  ochrony roślin
AU2017239848B2 (en) Novel compound and synthesis method therefor
WO2017046816A3 (en) Process for the preparation of derivatives of benzodioxole
PH12015501840A1 (en) Production method of pyridazinone compounds
TH2001002464A (th) การสังเคราะห์อนุพันธ์เอสเทอร์โบรอเนทและการใช้มัน
EP4053099A3 (en) Acrylic acid derivative-containing composition, and method for stabilizing acrylic acid derivative
MX2019012468A (es) Nuevos compuestos de fenilamina.
EA201400882A1 (ru) Способ стереоселективного синтеза 9-гидрокси-5-оксо-1,4-диазаспиро[5.5]ундеканов, содержащих защитные группы в 1,4-положениях
PH12015502060A1 (en) Hydrochloride salts of an antibiotic compound